Hospital or health organisation · founded 1913
City of Hope
Lancaster, United States · cityofhope.org/location/antelope-valley
- Citations, last 5 years
- 83.9k
- Works, last 5 years
- 7 099
- h-index
- 595
- Scientists listed
- 36
- Grants since 2016
- 654
Grants received
2022–2023 · research · R21
Using Senolytics to Improve Physical Function in Older Breast Cancer Survivors
Mina S Sedrak · City of Hope · funded by National Institutes of Health
2022–2027 · research · R01
The role and therapeutic potential of IGF2BP2 in MLL-rearranged leukemia
Jianjun Chen · City of Hope · funded by National Institutes of Health
2022–2027 · research · R01
Environmental Chemical Body Burden and Prospective Breast Cancer Risk in the Cancer Prevention Study-3 Cohort
Susan L. Neuhausen · City of Hope · funded by National Institutes of Health
2022 · program · P30
Novel targeted therapies for HPV-associated Non-AIDS-defining cancers (Biospecimens/Biocohort)
Steven Terry Rosen · City of Hope · funded by National Institutes of Health
2022–2027 · research · R01
Integration of epidemiology, pathology, immunology and outcomes in colorectal cancer
Stephen B Gruber · City of Hope · funded by National Institutes of Health
2022–2027 · grant · DP5
Biomarkers, mechanisms and modulation of oxidative stress associated risk factors in carcinogenesis
Yun Rose Li · City of Hope · funded by National Institutes of Health
2022–2026 · research · R01
The Role of miR-142 in the Transformation of Clonal Hematopoietic Disorders into AML
Guido Marcucci · City of Hope · funded by National Institutes of Health
2022–2026 · research · R01
Engineered anti-PSCA antibodies for immunoPET and targeted therapy of pancreatic cancer
Anna M Wu · City of Hope · funded by National Institutes of Health
2022–2027 · research · R01
Development of Microbial-Based Therapies to Suppress Macropinocytosis in Kras-Driven Cancers
Edwin Manuel · City of Hope · funded by National Institutes of Health
2022–2026 · research · R01
The Role of miR-142 in the Transformation of Clonal Hematopoietic Disorders into AML
Guido Marcucci · City of Hope · funded by National Institutes of Health
2022–2027 · research · R01
Mechanism and therapeutic opportunities of targeting the Tudor domain
Chun-Wei David Chen · City of Hope · funded by National Institutes of Health
2022–2027 · research · R01
BAFF-R CAR T cell therapy for ALL
Ibrahim Aldoss · City of Hope · funded by National Institutes of Health
2022–2026 · grant · DP5
Diversity Supplement to "Biomarkers, mechanisms and modulation of oxidative stress associated risk factors in carcinogenesis"
Yun Rose Li · City of Hope · funded by National Institutes of Health
2022–2026 · research · R01
Engineered anti-PSCA antibodies for immunoPET and targeted therapy of pancreatic cancer
Anna M Wu · City of Hope · funded by National Institutes of Health
2022–2027 · research · R01
Microbial- based targeting of major extracellular matrix components for improved therapy of pancreatic cancer
Edwin Manuel · City of Hope · funded by National Institutes of Health
2022–2026 · research · R01
An integrated toolkit combining computational systems biology techniques with molecular dynamics simulations to delineate functionality of GPCRs
Andrei Rodin · City of Hope · funded by National Institutes of Health
2022–2027 · research · R01
BAFF-R CAR T cell therapy for ALL
Ibrahim Aldoss · City of Hope · funded by National Institutes of Health
2022–2027 · research · R01
BAFF-R CAR T cell therapy for ALL
Ibrahim Aldoss · City of Hope · funded by National Institutes of Health
2022–2027 · career development · K23
Cytomegalovirus-specific Immune Reconstitution after Hematopoietic Cell Transplantation in the Era of Modern Antiviral Prophylaxis
Danniel Zamora · City of Hope · funded by National Institutes of Health
2022–2027 · research · R01
Define the effect of CLU SNP on the risk to Alzheimer's disease
Yanhong Shi · City of Hope · funded by National Institutes of Health
2022–2026 · research · R01
Engineered anti-PSCA antibodies for immunoPET and targeted therapy of pancreatic cancer
Anna M Wu · City of Hope · funded by National Institutes of Health
2022–2026 · research · R01
Role of the TET1 short isoform in MDS development and maintenance
Zhijian Qian · City of Hope · funded by National Institutes of Health
2022–2028 · research · R01
Intracerebroventricular (ICV) Administration of CD19-Targeting Chimeric Antigen Receptor (CAR) T cells for Treatment of Primary Central Nervous System Lymphoma
Stephen J Forman · City of Hope · funded by National Institutes of Health
2022–2025 · career development · K01
The role of Nrf2 in beta cell expansion during pregnancy
Sharon Alterzon · City of Hope · funded by National Institutes of Health
2022–2027 · research · R01
Development of Microbial-Based Therapies to Suppress Macropinocytosis in Kras-Driven Cancers
Edwin Manuel · City of Hope · funded by National Institutes of Health
2022–2027 · research · R01
Leveraging Digital Health Solutions to Reduce Learning and Functional Disparities in Children with Cancer
Sunita K Patel · City of Hope · funded by National Institutes of Health
2022–2027 · research · R01
An integrated toolkit combining computational systems biology techniques with molecular dynamics simulations to delineate functionality of GPCRs
Andrei Rodin · City of Hope · funded by National Institutes of Health
2022–2027 · research · R01
Leveraging Digital Health Solutions to Reduce Learning and Functional Disparities in Children with Cancer - Administrative Supplement
Sunita K Patel · City of Hope · funded by National Institutes of Health
2022–2027 · research · R01
Environmental Chemical Body Burden and Prospective Breast Cancer Risk in the Cancer Prevention Study-3 Cohort
Susan L. Neuhausen · City of Hope · funded by National Institutes of Health
2022–2027 · research · R01
Role of de novo pyrimidine biosynthesis in pathological cardiac remodeling
Zhao Wang · City of Hope · funded by National Institutes of Health
2022–2027 · research · R01
A Phase 1 Study to Evaluate Chimeric Antigen Receptor (CAR) T cells Targeting TAG72 in Patients with Recurrent Epithelial Ovarian Cancer
Saul Priceman · City of Hope · funded by National Institutes of Health
2021–2026 · research · R01
Unmasking the roles of viral glycoproteins in oral transmission of KSHV
Javier Gordon Ogembo · City of Hope · funded by National Institutes of Health
2021–2026 · cooperative agreement · U01
Mechanism of estrogen independent proliferation in ER+ breast cancer cells
Aritro Nath · City of Hope · funded by National Institutes of Health
2021–2026 · research · R01
Unmasking the roles of viral glycoproteins in oral transmission of KSHV
Javier Gordon Ogembo · City of Hope · funded by National Institutes of Health
2021–2025 · research · R01
Circulating Extracellular Vesicles in the Pathogenesis of Type 1 Diabetes
Susmita Sahoo · City of Hope · funded by National Institutes of Health
2021–2026 · research · R01
Targeting tumor-associated macrophages for triple-negative breast cancer treatment
Mingye Feng · City of Hope · funded by National Institutes of Health
2021–2026 · research · R01
Validation of epigenomic biomarkers for thyroid cancer diagnostics
Maria Hahn · City of Hope · funded by National Institutes of Health
2021 · program · P30
Caribbean Investigation of Cancer Stigma and its effect on Cervical Cancer Screening and HPV Vaccination
Steven Terry Rosen · City of Hope · funded by National Institutes of Health
2021–2026 · research · R01
Unmasking the roles of viral glycoproteins in oral transmission of KSHV
Javier Gordon Ogembo · City of Hope · funded by National Institutes of Health
2021–2026 · research · R01
Validation of Epigenomic Biomarkers for Thyroid Cancer Diagnostics
Maria Hahn · City of Hope · funded by National Institutes of Health